Eldred Kary

Eldred Kary is listed in filings as Director at Galectin Therapeutics Inc.. This profile follows SEC Form 4 activity through Feb 9, 2026, including purchase activity. Recent filings connect the profile to Galectin Therapeutics Inc. (GALT). The current snapshot covers public activity from Jul 23, 2024 to Feb 9, 2026. Reported amounts are shown as $810 to $2.6K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.